DEMIURGE TECHNOLOGIES AG

demiurge-technologies-ag-logo

Demiurge pioneers high-accuracy MoA-based prediction of clinical trial outcomes.

#SimilarOrganizations #People #Website #More

DEMIURGE TECHNOLOGIES AG

Social Links:

Industry:
Biotechnology Neuroscience

Founded:
2015-05-22

Address:
Zug, Zug, Switzerland

Country:
Switzerland

Website Url:
http://www.demiurge.technology

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
9.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Google GStatic Google Static Content


Similar Organizations

1200-pharma-logo

1200 Pharma

1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.

metis-therapeutics-logo

METiS Therapeutics

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

minerva-neuroscience-logo

Minerva Neuroscience

Minerva Neurosciences is a clinical-stage biopharmaceutical company

nimbus-therapeutics-logo

Nimbus Therapeutics

Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company.

Current Employees Featured

bragi-lovetrue_image

Bragi Lovetrue
Bragi Lovetrue CSO & CTO @ Demiurge Technologies AG
CSO & CTO
2016-01-01

idonae-lovetrue_image

Idonae Lovetrue
Idonae Lovetrue CEO @ Demiurge Technologies AG
CEO
2016-01-01

Founder


bragi-lovetrue_image

Bragi Lovetrue

idonae-lovetrue_image

Idonae Lovetrue

Official Site Inspections

http://www.demiurge.technology Semrush global rank: 7.27 M Semrush visits lastest month: 110

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.171
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Demiurge Technologies AG"

VALIDATION | DemiurgeTechnologies

Demiurge has achieved an 22-month-long public track record of 84% (103/123) accuracy in our prospective predictions of first-in-class phase 2 and phase 3 clinical trial results. as of 03 โ€ฆSee details»

Demiurge Technologies AG - Crunchbase Company Profile

Contact Email [email protected]; Demiurge pioneers high-accuracy MoA-based prediction of clinical trial outcomes. Products and Services. Powered by AI . ... 9,916 Number โ€ฆSee details»

Demiurge Technologies Company Profile 2024: Valuation, Funding ...

Is Demiurge Technologies a private or public company? Demiurge Technologies is a Private company. What is Demiurge Technologiesโ€™s current revenue? The current revenue for โ€ฆSee details»

PLATFORM | DemiurgeTechnologies

Demiurge Technologies delivers high-accuracy AI-based predictions of clinical trial outcomes for all diseases and offers clinical-efficacy-prediction-based valuation of biopharma assets for all โ€ฆSee details»

Demiurge Technologies - Products, Competitors, Financials, โ€ฆ

Demiurge Technologies specializes in the prediction of clinical trial outcomes using virtual patient models within the life sciences domain. The company offers a platform that generates โ€ฆSee details»

Demiurge Technologies AG Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Demiurge Technologies AG of Zug, ZUG. Get the latest business insights from Dun & Bradstreet.See details»

Demiurge Technologies - Company Profile - Tracxn

Nov 5, 2024 Founded by Idonae Lovetrue in the year 2015. Demiurge Technologies has 12 competitors. Demiurge Technologies - Developer of neural network models and neuromorphic โ€ฆSee details»

Demiurge Technologies - Overview, News & Competitors

Demiurge Technologies is a research-based AI-biopharmaceutical company that transforms publicly available life science data into precise disease models in areas with unmet medical โ€ฆSee details»

Demiurge Technologies AG - startup.ch

Demiurge Technologies AG: At Demiurge, we focus on the fastest convergence to the discovery of the universal blueprint of animal brains and the best design of mobile robots on earth and in โ€ฆSee details»

Demiurge Technologies - VentureRadar

By integrating neuroscience with deep learning in their shared domain of mobile agents that generalize all animals and robots, Demiurge is exclusively focused on translating the โ€ฆSee details»

Demiurge Technologies Company Information - Funding, โ€ฆ

Https://demiurge.technology. Demiurge Technologies AG is a Swiss AI startup that develops neural network models and neuromorphic chips. Stay up to date with our weekly newsletter. โ€ฆSee details»

Company profile from Demiurge Technologies AG on jobs.ch

Company profile of Demiurge Technologies AG, Hofstrasse 1a in 6300 Zug. Hire now for freeSee details»

Demiurge Technologies - Craft

Demiurge Technologies has 5 employees at their 1 location. See insights on Demiurge Technologies including office locations, competitors, revenue, financials, executives, โ€ฆSee details»

CULTURE | DemiurgeTechnologies

Skeptical faithfulness, prudent fearlessness and empathetic rationality are the three principles defining the Demiurge culture. top of page. VALIDATION. COVID-19 MODEL. NEWSROOM. โ€ฆSee details»

Demiurge Technologies - VentureRadar

" At Demiurge, we are redesigning the units of deep neural networks to solve the fundamental challenges of training data shortage and adversarial examples that are tethering all deep โ€ฆSee details»

Demiurge Inc.

Demiurge Inc. - Explore the boundaries of science and reality through our groundbreaking experiments.See details»

Demiurge Technologies AG Management Team | Org Chart

Demiurge Technologies AG employs 3 employees. ... demiurge.technology; 3 209670XXXX; 917209XXXX; 408910XXXX; View Similar People. Related Companies AurigaVision AG. 13 โ€ฆSee details»

AI-BIOPHARMA | DemiurgeTechnologies

We apply the algorithmic insights of the next generation of neural networks to replacing the inefficient blind-men-and-an-elephant-style data-driven approach to drug discovery with an โ€ฆSee details»

NEWSROOM - DemiurgeTechnologies

Apr 30, 2020 Demiurge AI Discovers PI3K inhibitors as a Novel Candidate Treatment Selective for 2019 Novel Coronavirus (COVID-19) SWITZERLAND, FRIDAY, FEBRUARY 14, 2020 โ€ฆSee details»

linkstock.net © 2022. All rights reserved